| Gene symbol | MS4A1 | Synonyms | B1, Bp35, CD20, CVID5, FMC7, LEU-16, S7 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11q12.2 | dbXrefs | |
| Description | membrane spanning 4-domains A1 | ||||
| GTO ID | GTC2254 |
| Trial ID | NCT04169932 |
| Disease | B-Cell Lymphoma | Non-Hodgkin's Lymphoma |
| Altered gene | CD20 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD20 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Unknown |
| Title | The Clinical Study of CD20 CAR-T Cells in Patients With Relapsed and Refractory B Cell Non-Hodgkin Lymphoma |
| Year | 2019 |
| Country | China |
| Company sponsor | Shanghai Longyao Biotechnology Inc., Ltd. |
| Other ID(s) | 20191023V1.1 |
| Cohort 1 | |||||||||
|
|||||||||